# NCT00352846 (NCT00352846)

> Effect of Zoledronic Acid on Chemotherapy Induced Bone Loss

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT00352846
- Phase: PHASE3
- Status: COMPLETED
- Sponsor: M.D. Anderson Cancer Center
- Conditions: Non-Hodgkin's Lymphoma; Lymphoma
- Interventions: Zoledronic Acid; Vitamin D; Calcium Carbonate
- Enrollment: 135
- Primary outcome: Percentage Change in Bone Mineral Density (BMD) T-Score From Baseline to 12 Months

## Commentary we found

- X threads: 45

## Order

Deep, $1,950, price fixed at order: https://www.erudio.com/contact?report=nct00352846

## Free build

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT00352846", "email": "<work email>"}; the inbox owner confirms by the emailed link.